IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways

Eiichiro Yumoto1, Harushige Nakatsukasa, Tadashi Hanafusa

  • 1Department of Medicine, Okayama University Graduate School of Medicine and Dentistry, Japan. yumoto-gi@umin.ac.jp

Insights

Insulin-like growth factor binding protein-3 (IGFBP-3) acts as a tumor suppressor in hepatocellular carcinoma (HCC). This study reveals IGFBP-3 activates growth suppression pathways, including TGF-beta and Rb, in HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Insulin-like growth factor binding protein-3 (IGFBP-3) is recognized for its role in mediating growth suppression and as a potential tumor suppressor gene.
  • The precise mechanisms by which IGFBP-3 exerts its growth-suppressive effects remain incompletely understood, particularly in the context of hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To investigate the expression patterns of IGFBP-3 transcripts in human HCC.
  • To elucidate the relationship between IGFBP-3 expression and the transforming growth factor-beta (TGF-beta) and retinoblastoma (Rb) signaling pathways in HCC.

Main Methods:

  • In situ hybridization was employed to detect IGFBP-3 transcripts in HCC tissues and metastatic nodules.
  • cDNA microarray analysis was performed to assess gene expression profiles in IGFBP-3-expressing HCCs.
  • Immunohistochemical analyses were conducted to evaluate the status of TGF-beta and Rb pathway components.

Main Results:

  • IGFBP-3 transcripts were detected in 10% of HCCs (6/57), predominantly in moderately/poorly differentiated tumors with intrahepatic metastasis, and consistently in lung metastatic nodules.
  • cDNA microarray data indicated upregulation of TGF-beta and Rb pathway genes in HCCs expressing IGFBP-3.
  • Immunohistochemistry revealed pathway abnormalities: loss of phosphorylated-Smad2 in 2 cases and overexpression of phosphorylated-Rb in 4 cases among the 6 HCCs with IGFBP-3.

Conclusions:

  • The findings suggest that IGFBP-3 plays a role in mediating growth suppression signals in HCC.
  • IGFBP-3 appears to exert its effects through the TGF-beta and/or Rb signaling pathways.
  • Further research into IGFBP-3's function could offer novel therapeutic strategies for HCC.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...